Numerous epidemiological studies have implicated cigarette smoking as a cofactor in the progression to cervical cancer. Tobacco-associated hydrocarbons have been found in cervical mucus, suggesting a possible interaction with human papillomavirus (HPV)-infected cells. The polycyclic aromatic hydrocarbon benzo-[a]pyrene (BaP) is a major component of cigarette smoke condensate that has received significant attention due to its ability to induce carcinogenesis. We have previously demonstrated by conventional methods for determining viral titer that high concentrations of BaP increase HPV31b titers within the context of organotypic raft cultures compared with the level for vehicle controls. However, a definitive mechanism for explaining this increase in viral titer was lacking. Here, we show that BaP treatment activates the Ras-Raf-Mek1/2-Erk1/2 signaling pathway. The importance of Erk1/2 pathway activation to the BaP-mediated increase in viral titer was determined by Erk pathway inhibition with multiple Erk1/2 pathway inhibitors. Finally, BaP treatment activated p90RSK and its downstream target CDK1. These data indicate that the Erk1/2 signaling pathway plays an important role in mediating the response to BaP treatment that ultimately leads to increased viral titers.Cervical cancer is the third most common female cancer and is the second most common cause of cancer-related deaths among women (67). More than 90% of all cervical cancer cases are associated with human papillomavirus (HPV) infection (76,(88)(89)(90). Papillomavirus infections are established in basal epithelial cells, where the viral genome is maintained as an episome, tethered to the host genome (22,80,86). HPV genome replication, gene expression, and virion synthesis are tightly linked to the differentiation state of the infected cell (51,57,61). The progression to cervical cancer is associated with the integration of high-risk HPV genomes into host chromosomes (18,30). However, only a small percentage of women infected with high-risk HPV types (such as HPV16, HPV18, and HPV31) actually progress to cervical cancer (7, 21), suggesting a role for cofactors in the progression to cervical cancer.Ample epidemiological evidence exists to implicate cigarette smoking as a cofactor with HPV infection in cervical cancer progression (4,24,43,55,70,82,85). Polycyclic aromatic hydrocarbons (PAHs) are among the numerous carcinogens associated with cigarette smoking. Benzo[a]pyrene (BaP) is a PAH that is present at roughly 8 to 25 nanograms per cigarette (27) and is found at elevated levels in the cervical mucus of women who smoke (48). BaP is metabolized via cytochrome P450 enzymes to intermediates or metabolites, some of which have the potential to bind to DNA, forming DNA adducts (16,72). Unrepaired DNA adducts represent an important initiator of carcinogenesis (27,73). PAHs like BaP have also been shown to increase cell proliferation, likely through the activation of specific signaling pathways (8,31,62,74,75). BaP has been shown to activate both mitogen-activa...